Search Results 171-180 of 20781 for ulcerative colitis
Olsalazine is used in patients who have had ulcerative colitis to prevent the condition from occurring again. It works inside the bowel by helping to reduce ...
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...
... ulcerative colitis. Mayo Clinic researchers conducted the first clinical study of mesalamine and discovered that genetic differences significantly affected ...
... ulcerative colitis. Mayo Clinic researchers conducted the first clinical ... IBD medicine as well as the IBD drugs azathioprine and mercaptopurine.
Six of the seven patients in the chart review were diagnosed with Crohn's disease and one was diagnosed with ulcerative colitis. Three patients were treated ...
Pharmaceutical trials of novel agents to treat IBD. Significance to patient care. Certain patients with ulcerative colitis and Crohn's disease are at an ...
11–16, in San Diego. More than 1.5 million Americans have Crohn's disease or ulcerative colitis , the most common forms of inflammatory bowel disease (IBD).
IBD encompasses a range of disorders involving inflammation of the digestive tract, including ulcerative colitis and Crohn's disease. Symptoms for both ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.